Gabriel Tinoco
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma (NCT06528769) | Gabriel Tinoco | 2025-09-10 |
Track Gabriel Tinoco automatically
Every clearance here is in the API, with alerts when new ones post.